Vuebox®️在线申请试用版 Vuebox®是Bracco的专利定量分析软件，适用于临床医生和研究人员，用于增强超声定量组织灌注。欢迎联系我们，在线申请使用试用版。

Bracco è Marchio Storico di Interesse Nazionale L’azienda, nata nel 1927 e oggi leader globale nella diagnostica per immagini, entra a far parte dell’esclusivo gruppo di imprese storiche che rappresentano la punta di diamante del Made in Italy.

Our New Iodine Recollection Pilot and Re.Viva Re.Viva works to capture and redeploy used substances in the positive momentum of the circular economy: the Bracco Iodine Recollection Pilot 

Unlocking the AI Revolution Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”

Bracco Imaging announces global agreement with Subtle Medical Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI.

Vueway® (Gadopiclenol) Receives Positive CHMP Opinion The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Gadopiclenol in adults and pediatric patients older than 2 years of age.

Bracco group celebrates twenty years of Bracco Spin During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires

Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.

布兰德·普洛特尼克与MRI 筛查 在 2021 年被诊断为乳腺癌后，Brand 成为了早期 MRI 筛查、乳房切除术后的美学平坦闭合以及癌后健康改善的重要倡导者。越早进行 MRI 筛查，就能越早为健康做好全面的规划。

AI 助力医疗保健行业和诊断成像的创新 创新是博莱科核心业务的重要驱动力，公司多次邀请专家探讨人工智能（AI）如何帮助加速药物研发并提高诊断准确性。未来，医疗行业和全人类将从人工智能和机器学习中获益良多。